Tag: AVT02

Alvotech’s BLA for AVT02 receives a comprehensive response letter from the US FDA.

April 15, 2023
The US Food and Drug Administration (FDA) has responded completely to Alvotech’s Biologics Licence Application (BLA) for AVT02,…
WhatsApp Telegram